A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma
Abstract Background Stomach adenocarcinoma (STAD) is a highly heterogeneous disease and is among the leading causes of cancer-related death worldwide. At present, TNM stage remains the most effective prognostic factor for STAD. Exploring the changes in gene expression levels associated with TNM stag...
Main Authors: | Zining Liu, Hua Liu, Yinkui Wang, Ziyu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-022-02510-8 |
Similar Items
-
Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis
by: Mingze Lu, et al.
Published: (2021-05-01) -
Synchronous Primary Adenocarcinoma and Gastrointestinal Stromal Tumor in the Stomach
by: Hamza Çınar, et al.
Published: (2014-03-01) -
Complement system-related genes in stomach adenocarcinoma: Prognostic signature, immune landscape, and drug resistance
by: Xiaoxia Tong, et al.
Published: (2022-09-01) -
Synchronous adenocarcinoma and gastrointestinal stromal tumor in the stomach - report of two cases
by: Stojanović Dragoš, et al.
Published: (2019-01-01) -
A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma
by: Zaisheng Ye, et al.
Published: (2021-06-01)